| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  NEOGAP Therapeutics AB Science for cure. NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy. Biopharmaceutical company, Immunotherapy, and Immuno-oncology Type: | 0 | 0 | 0 | 25 |
 | CryoLogyx Revolutionizing cell-based assays with assay-ready cryopreservation solutions for faster, reliable results CryoLogyx specializes in developing and producing high-quality, cryopreservation solutions. The cryopreserved cells are designed to cater to the critical needs of the drug discovery, which is powered by the patented formulation - CryoshieldTM. Freezing and thawing processes can be particularly stressful for cells, often resulting in reduced viability and recovery due to ice crystal formation and other factors. And the repetitive tasks of cell culture, including numerous counting and handling procedures, take significant time that researchers could otherwise dedicate to more critical aspects of their research. At CryoLogyx, we … Type: | 0 | 0 | 0 | 11 |
 |  FundaMental Pharma We Fight Neurodegeneration FundaMental Pharma is engaged in pioneering research around a breakthrough molecular mechanism that allows to safely counteract glutamate neurotoxicity (also known as excitotoxicity) by specifically targeting the interface between NMDA receptors and TRPM4 channels with small molecule TwinF interface inhibitors (Yan et al., Science 2020). TwinF interface inhibitors constitute an entirely new class of drugs that safely ameliorate glutamate neurotoxicity, a common cause of neurodegeneration. Our initial focus is on amyotrophic lateral sclerosis (ALS). The applicability of our molecules extends to a range of neurogenerative disorders including Alzheimer’s disease (AD). Type: | 0 | 0 | 0 | 12 |
 | Onego Bio Onego Bio is a game changer food-biotech company producing animal-free egg protein with precision fermentation. Onego Bio is a US-Finnish food-biotech company revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen®, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly efficient and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected the … Type: | 3 | 2 | 1 | 39 |
 | Asgard Therapeutics Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient. Cell Reprogramming, Cancer Immunotherapy, and … Type: | 1 | 0 | 1 | 24 |
 | Bmind [Automatic translation follows] There are no pre-established paths for psychological well-being. BMind helps you design yours, step by step. BMind offers an online psychological support service accessible to all and efficient, tailor-made for each person. Our goal 💪🏼 There are no pre-established paths for psychological well-being, but Bmind wants to help people design theirs in a totally personalized way, without ever neglecting the individual differences of each patient. The perfect match exists ✅ The match between psychologist and patient occurs automatically but accurately and reliably, so that the professional can fully reflect the patient's needs and accompany them on their … Type: | 0 | 0 | 0 | 19 |
 | Oncostellae Novel small-molecule drugs in immunology, fibrosis and women health Clinical-stage biotech company founded by serial entrepreneurs and owned by private & institutional investors. Discovery and development of new chemical entities with strong IP and worldwide rights targeting indications with high unmet medical need in immunology, fibrosis and women health. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, Inflammation and autoimmune diseases, IP generation, IBD, Ulcerative Colitis, Crohn's disease, Fibrosis, and Uterine fibroids Type: | 0 | 0 | 0 | 11 |
 | Eisbach Bio GmbH Targeting synthetic lethality in cancer Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game. Type: | 2 | 0 | 2 | 12 |
 | Zilico Limited Real-time medical diagnostics Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs. ZedScanTM, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal cervical screening result, increasing diagnostic accuracy and delivering health economic benefits. Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable … Type: | 7 | 1 | 6 | 7 |
 | NIOX® NIOX Group plc is a dedicated diagnostics and monitoring company focused on respiratory disease. NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary … Type: | 4 | 1 | 1 | 124 |
 | Francelab [Automatic translation follows] At FranceLab we are dedicated to manufacturing medicines with the highest quality standards. Francelab is a national pharmaceutical company dedicated exclusively to oral hypoglycemic medications. Located in the Tigre industrial park. Our Vision: To become a company with a national presence that achieves commercial results based on quality, friendship and communication with doctors, patients, social works and distribution channels. Our Mission: To produce medicines and relationships that exceed the quality standard Our commitment: To promote and maintain a culture of respect. We do not discriminate based on gender, religion, ethnicity, nationality, culture, social group, disability, illness, sexual … Type: | 0 | 0 | 0 | 29 |
 | Icosagen The Art of Antibody Discovery and Production. Mammalian CRDMO - From Discovery mgs to Clinical GMP kgs. We're a leading biotechnology company, providing streamlined or custom-tailored services for global clients in pharmaceutical, biotechnology industries, and academia. We've been a privately held family business since 1999, and have grown into a leading mammalian Contract Research, Development, and Manufacturing Organization (CRDMO). The CRDMO approach allows us to cover the entire spectrum of pre-clinical and clinical services - from the initial stages of target discovery and development, to cell line development, and manufacturing of mammalian therapeutic proteins, up to 1000 L scale. In … Type: | 0 | 0 | 0 | 131 |
 | MI:RNA Diagnostics Veterinary diagnostic testing evolution, innovation, research and solutions MI:RNA Diagnostics have developed a novel early disease detection technology for the veterinary market that uses microRNA biomarkers to accurately identify if disease is present, through blood sample analysis. By combining this method with an artificial intelligence learning model to enable interpretation, they have adopted a true precision medicine approach. Paving the way, they hope, for many other innovative solutions in this field. It is their mission to reduce disease through research and innovation, resulting in a cascade of ethical, environmental, and economic benefits. Type: | 5 | 0 | 5 | 21 |
 | Evamed [Automatic translation follows] Experts in the clinical evaluation of medical devices Evamed is a C.R.O expert in the clinical evaluation of medical devices. We support manufacturers, learned societies and public bodies on their interventional studies, registries and observational studies. Our experience and Evamed's strong medical device culture make it a trusted player and a privileged partner for your clinical study projects. We can support you throughout your project (Protocol, eCRF, Steering, Monitoring, Data-management, Statistics, Reports) or collaborate on specific stages. Do you want to carry out a post-marketing surveillance study, obtain your CE marking or your reimbursement? Evamed ensures the … Type: | 8 | 3 | 7 | 38 |
 | Euro-Pharmat [Automatic translation follows] Expertise, skills, training, objective information for the proper use of medical devices. Objective, validated information on Sterile Medical Devices. For nearly 40 years, the experience of real-time information. A training activity through annual National Days and a training catalog. French pharmaceutical learned society of medical devices defined by its new statutes in 2021. Information Database and Training Organization Type: | 14 | 2 | 11 | 8 |
 | Bond Pet Foods Reimagining pet nutrition so people, pets, farm animals and the planet all win. We are an Ally For All Animals®. Reimagining meat for pet nutrition so people, pets, farm animals and the planet all win. Type: | 3 | 1 | 2 | 31 |
 | Oobli Seriously sweet proteins. We make seriously sweet proteins that are changing the world, one bite at a time. Sweetness from protein—not sugar—is the breakthrough you’ve been waiting for. They’re good for your body and good for the planet, but it’s their amazing taste that will keep you coming back. The gut-friendly, diabetic-friendly, all flavor, no compromise win we all deserve. We’re a team of biologists, engineers, food-lovers, health advocates and environmentalists on a mission to transform the world with healthy sweetness. Come join us in building a sweeter future for all. Try our NEW Lemonade: 80% less sugar, no alternative … Type: | 2 | 0 | 0 | 42 |
 | FlapJacked® High Protein Snacks & Indulgences that Satisfy Cravings and Keep You on Track with Your Goals. FlapJacked was founded in 2012 by Jennifer and David Bacon as a result of making changes to their diet to better serve the needs of their 5 children including their son Jace, who has Autism. Nutrition and fitness are always at the forefront of the FlapJacked Founders and their family. FlapJacked products are developed with specific goals in mind; to be delicious, protein-packed, fiber-rich and easy to prepare (just add water). Protein Pancake & Baking Mix and Mighty Muffins with Probiotics Type: | 0 | 0 | 0 | 8 |
 |  Lupii Lupii is unleashing the power of the small-but-mighty lupini bean to keep you fueled, fed, and running like a boss. Lupii is unleashing the power of the small-but-mighty lupini bean to keep you fueled, fed, and running like a boss. Our hero ingredient, the lupini bean, has 3x more protein than eggs, 3x more fiber than oats, is jam-packed with vitamins, and has all 9 essential amino acids. Whether you’re vegetarian, vegan, reducetarian, or just plain awesome– eating Lupii is the perfect way to nourish your body, mind, and planet. Type: | 0 | 0 | 0 | 4 |
 | Origen Farms [Automatic translation follows] Harnessing Resources for a Smarter Future Breeding Insects for Flour in a Smart and Sustainable Way The world's population is growing and is expected to reach 9.725 billion people by 2050. The demand for animal-derived protein is expected to increase, which will also increase the use of land and water for that purpose, increase greenhouse gas emissions and, therefore, generate an increase in the environmental crisis. These factors show that the current way of producing protein is unsustainable. While the population of the West consumes too much, the population in developing countries does not obtain the necessary … Type: | 0 | 0 | 0 | 4 |
 | BIOMILQ Unlocking human potential with breakthrough mammary biotechnology. BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies. Femtech, Biotechnology, infant nutrition, Social Venture, and Female Founder Type: | 4 | 1 | 3 | 25 |
 | Hudson River Biotechnology We provide solutions to enhance the functions of plants using CRISPR plant breeding and smart delivery systems Hudson River Biotechnology delivers technologies that are needed to meet the challenges of our food systems. In the face of a changing climate, the need to achieve sustainability goals and a growing population, current agricultural practices are becoming untenable. Only new technological approaches will transform agriculture into a sustainable and efficient activity. Hudson River Biotechnology has developed technologies to enhance the functions of plants using CRISPR and deliver agrochemical inputs efficiently through targeted, nanotechnology-based systems. By providing these technologies to its partners, HRB … Type: | 4 | 1 | 3 | 32 |
 | MIRAI FOODS We are developing real meat - cultivated directly from animal cells in Switzerland! We are developing real meat - cultivated directly from animal cells ! Our mission is to provide delicious, high quality cultivated meat at a fair price. Better for people, animals and the planet. Our vision is to become a household brand for cultivated meat, thereby accelerating the transition to a global food system that is environmentally, ethically and economically sustainable. cultivated meat, lab grown meat, clean meat, and cultured meat Type: | 2 | 1 | 1 | 6 |
 | CTRL Created for the community, built for the cultureTM - A Meal Replacement, Catered to Real Life 🥣 In today's world where everyone is always go-go-go, it has become a normal thing to skip meals, overpay for delivery, or eat fast food too much. Our mission is to provide healthier and great-tasting alternatives to give your body all the essential nutrients, proteins, carbs, and fats it needs to function optimally. Type: | 1 | 0 | 1 | 14 |
 | Relief srl Stop leaking without stopping your life Relief is developing an innovative magnetically-controlled medical device against stress urinary incontinence, already patented and tested on humans. Our solution is uni-sex, easy to use, minimally invasive, fast to insert/remove, invisible, and able to drastically improve the quality of life of millions of people worldwide who can no longer live a normal daily life with their families. urinary incontinence, engineering, artificial sphincter, innovative solution, and medical device Type: | 1 | 0 | 0 | 3 |
 | eMyosound eMyosound develops an innovative medical device to diagnose heart failure using ultrasound. Type: | 2 | 2 | 0 | 7 |
 | Aurion Biotech We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. Type: | 1 | 1 | 0 | 71 |
 | Mycovation Empowering Better Food./ We’re Fundraising Mycovation is Asia's first mycelium protein company building a portfolio of food ingredients that are vegan, nutritious, affordable and sustainable. Type: | 1 | 0 | 1 | 4 |
 | Prime Roots Prime Roots is making plant-based deli classics. Join our team & build a better food system! Prime Roots is celebrating the culture of meat by reimagining protein itself. Join our team & build a better food system from and for the planet. Type: | 2 | 2 | 0 | 41 |
 | Shiok Meats Shiok Meats is a cultivated seafood and meat company based in Singapore. Real meats, delicious, nutritious. Shiok Meats is a cultivated meat and seafood company – the first of its kind in Singapore and South-East Asia. “Shiok” in Singapore and Malay slang means fantastic, delicious, and simply, pleasure. Shiok Meats also owns SEA’s first cultivated red meat company, Gaia Foods. Our mission is to bring delicious, sustainable, and healthy seafood to your table, using our technology to grow meat from healthy cells instead of animals. Currently, we produce crustaceans like shrimps, crabs, lobsters and are the first in the world … Type: | 5 | 3 | 1 | 11 |
 |  Inomed Health Innovating Medical Devices Inomed Health Limited is a UK distributor of innovative medical implantable and disposable devices to the NHS and private healthcare institutions. We are a focused company supporting customers and manufacturers to constantly improve the way surgical and non-surgical treatments are performed, delivered through better medical technology to improve the lives of patients. Medical Devices, Interventional Radiology, Biopsy Devices, and Bariatric Health & General Surgery Type: | 1 | 1 | 0 | 2 |
 | Pumpinheart Novel Medical Devices to treat Heart Failure with preserved Ejection Fraction (HFpEF) Novel Medical Device to treat Heart Failure with preserved Ejection Fraction Type: | 2 | 0 | 2 | 7 |
 | aVaxziPen aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens. Type: | 0 | 0 | 0 | N/A |
 | Thermidas Oy Thermal imaging solutions trusted by medical professionals Thermidas Oy is a Finnish health technology company established in 2008. Thermidas' infrared (IR) thermal imaging system is a novel imaging method supporting screening, early diagnostics, and evaluation of treatment effectiveness. At the core of the solution is an easy-to-use thermal imaging application developed by the company. Thermidas' IR thermal imaging system is the first CE-approved medical device IR-thermal imaging system in the world. Thermography, Thermal imaging equipment, Thermal image analysis software, FDA Cleared, and CE 0598 Certified Type: | 2 | 0 | 2 | 13 |
 | Mirai Medical Precision Cancer Therapy - - MedTech Innovator '23 A culture of innovation, a passion for excellence At Mirai Medical, we are passionate about developing technology that greatly improves cancer outcomes and enhances patient experiences. Following intensive research and development, Mirai Medical was formed from a team with over 50 combined years of experience in the areas of pulsed electrical fields, electroporation for cancer, immunotherapy and medical device development to address critical unmet challenges in cancer treatment. We have developed unique IP that allows for outpatient delivery of ePORE therapy which greatly facilitates the ease and improves the outcome of cancer … Type: | 2 | 0 | 0 | 21 |
 | Renovos Biologics Limited Next-generation regenerative medicine solutions, pioneering use of synthetic nanoclay gels for tissue regeneration. Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton. Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite. Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Cell Based Assays, and Orthopaedics Type: | 0 | 0 | 0 | 11 |
 | Santero Therapeutics A start-up biotech active in the field of antibiotics discovery. Santero Therapeutics is a start-up biotech active in the field of antibiotics discovery. We are developing first-in-class, novel generations of drugs to fight multiple resistant pathogens Type: | 0 | 0 | 0 | 15 |
 | Kinarus Therapeutics Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases. Kinarus Therapeutics (SIX:KNRS) is a clinical-stage pharmaceutical company focused on bringing novel, patient-focused treatments for viral, respiratory, and ophthalmic diseases. Kinarus was incorporated in Basel, Switzerland in 2017. Our lead drug candidate is an oral combination of a clinical-stage P38 mitogen activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, and a second drug, together enabling an oral, long-term effective treatment. Kinarus has launched a large Phase 2 clinical trial in hospitalized Covid-19 patients with the aim to reduce mortality and duration of hospital stay. The … Type: | 0 | 0 | 0 | 5 |
 | Topadur Pharma AG Disruptive Therapies for Aging Diseases Topadur Pharma AG is a Swiss biopharmaceutical start-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R&D Pharma. Topadur’s vision is to improve patients’ quality of life by providing highly effective and safe drugs for unmet medical conditions. Topadur has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases like chronic … Type: | 0 | 0 | 0 | 14 |
 | SEED Biosciences One Click, One Cell We are SEED Biosciences, a spinoff from the Swiss Federal Institute of Technology (EPFL). We make DispenCell. One click, one cell. DISPENCELL is an automated laboratory instrument designed for fast, easy, and gentle single cell isolation. DISPENCELL is a pipetting robot designed to be compact, gentle, and intuitive, yet compliant with the most stringent regulatory standards. Designed by scientists for scientists, DISPENCELL has been thought to quickly integrate your lab routine in a plug-and-play approach. Flexible and effortless, DISPENCELL operates equally under sterile conditions in a culture hood, or on a simple benchtop. Its unique technology … Type: | 1 | 1 | 0 | 19 |
 | iCellate Medical AB Cancer profiling for precision oncology and early cancer detection iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing. Cancer Diagnostics, Circulating Tumor Cells (CTC), Liquid Biopsy, Next Generation Sequencing, CDx, Hereditary Cancer, Early Detection, Cancer, and Solid Tumors Type: | 0 | 0 | 0 | 12 |
 | revyve Simple, sustainable microbial ingredients that unlock the future of food At revyve, we produce simple, sustainable ingredients from circularly sourced microbial biomass like brewers yeast. Our ingredients are highly functional and can perfectly replace E-numbers and animal ingredients. Revyve's ingredients are key to revolutionising the taste and texture of alternative proteins and unlocking the future of food. alternative protein, taste, texture, functionality, and future of food Type: | 6 | 2 | 5 | 28 |
 | iOnctura Developing precision small molecules to combat hard-to-treat tumors. iOnctura is a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers with precision oral small molecules that target cancers in novel ways. The bold new treatments extend lives and improve healthspans, changing the outlook for patients and their families. Two therapeutic candidates have progressed into mid-stage clinical development: roginolisib is the first allosteric modulator of PI3Kδ and cambritaxestat is the only autotaxin inhibitor in clinical development to treat cancer. oncology, drug development, and clinical development Type: | 6 | 2 | 4 | 26 |
 | Rosa Biotech Biosensing. Reimagined. Rosa Biotech is an AI-driven biosensing and diagnostics company based in Bristol. Our mission is to provide outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology. We have developed a novel sensing platform that leverages the rapid and precise approach honed over millions of years in the olfactory systems of mammals. By using machine learning we are capable of discriminating between complex biological samples and are able to predict commercial and clinical outcomes. Biosensing, Diagnostics, AI, Machine learning, Medicines manufacturing, Industrial biotechnology, Biotechnology, Biodesign, Chemistry, Protein design, Peptide design, Sensing, and Detection Type: | 0 | 0 | 0 | 3 |
 | AstriVax Committed to address real-world challenges in vaccinology AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad … Type: | 0 | 0 | 0 | 36 |
 | Lentitek Enabling the next generation of medicines Lentitek is developing solutions to help amazing therapies get to more people. Gene therapies, and gene-modified cell therapies such as CAR-T are proving themselves as incredible life changing and life saving therapies. However they face an issue with the production yield of the viral vector. Lentitek is developing solutions to improve the viral yield by 10 fold and beyond. This will help these developers reduce production costs and allow these amazing therapies get into more people who really need it! Type: | 1 | 0 | 1 | 5 |
 | Anavo Therapeutics BV UNLOCKING THE PHOSPHATASE TARGET CLASS Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures. drug discovery, phospatase biology, and oncology Type: | 0 | 0 | 0 | 25 |
 | MUVON Therapeutics AG Regain control with personalized muscle regeneration MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life. Type: | 0 | 0 | 0 | 20 |
 | Halo Therapeutics The DeepTech Health Company The DeepTech Health Company Biotechnology, Virology, Antivirals, Small Molecule Drugs, Drug Development, and Pharmaceuticals Type: | 4 | 0 | 4 | 4 |
 | Oniria Therapeutics A shift in cancer treatment methodology makes a world of difference. A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme. Biotechnology, cancer, cell … Type: | 4 | 0 | 3 | 15 |
 | smartbax Developing novel multi-targeted antibiotics with extraordinary potency against multi-drug resistant bacteria. smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Type: | 2 | 0 | 2 | 5 |
 | Anocca Engineered Immunity Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely … Type: | 1 | 0 | 1 | 112 |
 | Saphenus Medical Technology [Automatic translation follows] A new therapy for less pain and safe walking after amputation. With the sensory feedback system Suralis. Saphenus is a manufacturer of sensory feedback systems with the aim of improving the quality of life of people with leg and foot prostheses. "The prosthesis should adapt to the person and not the other way around," is one of Saphenus' core messages. Saphenus has developed a multi-stage therapy specifically for people who have lost a limb and are complaining of pain, which combats pain and at the same time improves the quality of walking. Saphenus works with leading research … Type: | 1 | 1 | 0 | 19 |
 | Capitainer Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime. We have developed a microsystem based technology that offers a solution for near-patient blood sampling e.g. at home. Patients can themselves conveniently leave blood samples (as dried blod spots) and send it by mail to a laboratory for analysis. This is possible through our new disposable sampling chip that can meter and store an exact blood volume which allows for quantitative measurements, something that so far not has been possible. This is of particular importance for patients requiring continuous therapeutic drug monitoring. Our technology will reduce the … Type: | 2 | 0 | 2 | 27 |
 | hg medical GmbH & USA Technology lives here! HG Medical is a world class manufacturing centre of excellence and partner to the extremity and spinal orthopaedic market. HG Medical has state of the art facilities in Germany and the USA, and offers unrivalled expertise in the engineering development and manufacturing of extremity and spinal implants. Our philosophy is one of partnership and our commitment to quality is uncompromising. Both facilities in Germany and the USA are ISO 13485 Certified and CFR 820 Compliant. Medical Device, Design for Engineering, Precision Engineering , Product Development , Project Mnagement, ISO 13485, and FDA CFR 820 Type: | 0 | 0 | 0 | 71 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 44 |
 | FoodSquared The Future of Shellfish | We’re fundraising! FoodSquared is a B2B FoodTech company using a “patent pending” process and proprietary ingredient formulations to create next generation plant-based shellfish, starting with plant-based shrimp. Farmed shrimp have the largest carbon footprint per 100g protein after beef. We want to make that transition to plant-based shrimp easy by making great tasting and healthy alternatives. Our shrimp not only looks, tastes and feels like a native shrimp but our innovative process and ingredients also allows our product to benchmark the protein content and nutritional profile of a native shrimp unlike other plant-based shrimp products … Type: | 1 | 0 | 1 | 3 |
 | HEARTNET | Techstars '23 Solving fake and falsified medicines. Solving the $200billion epidemic of fake and falsified medicine Trade in counterfeited and falsified drugs has reached over 200 Billion dollars and the WHO warns that this problem is going to get worse. Hundreds of thousands of deaths are caused by faked and falsified drugs in Africa every year. We help Pharmaceuticals comply with track and trace to fight fake and falsified drugs. Type: | 1 | 0 | 1 | 3 |
 | LiberaBio Addressing "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells. LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, and Cytotoxics Type: | 2 | 1 | 2 | 11 |
 | PD Neurotechnology Ltd. Medical solutions PD Neurotechnology Ltd is a high-tech medical device company, founded in London, UK. The Greek Branch is based in Athens, Greece and the main activity of the company is carried out in the R&D and production, which is located in Ioannina, Greece. The company focuses its activities on researching, developing, producing and selling wearable medical devices and solutions for monitoring and supporting treatment of movement disorders. Its first solution is PDMonitor which is a sophisticated expert eco-system for patients with Parkinson’s Disease. Type: | 0 | 0 | 0 | 22 |
 | NUCAPS 🔬 New encapsulation technology for the industrial development of Nanocapsules and Biocapsules 💊 Green Nanotechnology NUCAPS@ is a consortium comprised by two Pharmaceutical companies (Laboratorios Cinfa and IDIFARMA), a Food Technological Center (CNTA) and the University of Navarra. T his consortium has developed new solutions based on the use of Food proteins (GRAS) as casein, zein or soya for the oral delivery and controlled release of drugs/actives and/or microorganisms. Nanotechnology, Encapsulation, Nanoencapsulation, Microencapsulation, Food, Nutrition, Cosmetic, Farmaceutic, and Pharmaceutical Type: | 10 | 2 | 3 | 20 |
 | SynaptixBio Ltd. Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, … Type: | 2 | 0 | 2 | 4 |
 | MicroHarvest Delivering better* protein ingredients, today. MicroHarvest is a BioTech company that developed the fastest protein production technology in the world. As we face a projected 50% increase in global protein demand by 2050, our innovative protein solution is not only timely but essential. Today's food system contributes to 26% of global CO2 emissions, therefore our vision is to dramatically reduce this footprint by offering accessible nutrition for a healthier planet. 💪 We invest in nature by harnessing the power of microorganisms to deliver better* protein ingredients, today. * Sustainable * Nutritious * Scalable Using the natural efficiency of these powerhouses … Type: | 10 | 4 | 9 | 41 |
 | Phialogics - The immune tolerance company Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases. Our immune checkpoint activators protect patient’s organ tissue. Unique approach : - Potential for BEST-in-class super agonist against immune-mediated tissue damage - High selectivity for active T-cells - Proof of concept in relevant human in vitro models and mouse model of disease Type: | 1 | 0 | 1 | 4 |
 | PureIMS 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery PureIMS is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops®. The focus is on the treatment of systemic and respiratory diseases with significant unmet medical need. The company’s leadership team consists of seasoned life sciences executives who bring long-lasting and complementary experience in leading drug development, addressing applicable scientific issues and pursuing commercial and business development & licensing opportunities. They obtained their experience in leading positions with mid-size and top-5 global … Type: | 0 | 0 | 0 | 9 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 26 |
 | Alia Therapeutics On-target gene therapies Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications. Type: | 0 | 0 | 0 | 14 |
 | Moolec Science Science in Food Ingredients We are a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. Our mission is to create unique food ingredients by engineering plants with animal protein genes. Moolec’s technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Our technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company’s product portfolio and pipeline leverages the agronomic efficiency of broadly … Type: | 3 | 1 | 2 | 20 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 1 | 0 | 1 | 48 |
 | hemotune AG We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients … Type: | 3 | 0 | 1 | 24 |
 | Neurosoft Bioelectronics Soft Minimally Invasive Brain Computer Interfaces At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible. Type: | 4 | 2 | 3 | 18 |
 | Hylomorph pioneering innovation in preventive medicine Hylomorph is an innovative Medtech company engineering innovative medical devices and drug-device combos that prevent implant complications and ensure patients' well-being post-surgery. At Hylomorph, we believe that every person deserves access to the best possible healthcare. That is why we are committed to developing innovative solutions that address medical needs and improve patient outcomes. By leveraging cutting-edge technologies and collaborating with healthcare professionals, we strive to make a positive impact in the lives of individuals and their families. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality … Type: | 1 | 0 | 1 | 12 |
 | CUTISS AG Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries Our mission: to give patients back more of their own skin to make them well again. CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation. We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries. Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently … Type: | 8 | 2 | 6 | 56 |
 | EggField Science driven protein company focusing on egg alternatives and helping gastronomy and industry to plant based growth. Pflanzliche Ei-Alternativen vom Feld für Industrie und Gastronomie. natürlich - clean label - ökologisch - vegan - swiss made Type: | 3 | 2 | 1 | 12 |
 | Ariceum Therapeutics Developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following … Type: | 1 | 1 | 1 | 38 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 7 | 1 | 0 | 65 |
 | NunaBio Limited Synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies. DNA, Custom DNA, Gene Synthesis, Synthetic Biology, Biotechnology, and DNA Synthesis Type: | 4 | 0 | 3 | 22 |
 | Manus Neurodynamica Prioritising Parkinson's Disease and other neurological conditions with earlier diagnosis and appropriate care. Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our disruptive technology has potential to be used across applications such as screening, rehabilitation and drug development and medicine optimisation, streamlining referrals, reducing costs and increasing the efficiency of specialist services. We are looking for interested researchers, clinicians and practitioners to collaborate in situ assessment and testing of the NeuroMotor pen, as well as investors for the further … Type: | 1 | 0 | 1 | 15 |
 | CHARM Therapeutics Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients. CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients. Type: | 6 | 0 | 6 | 68 |
 | Complement Therapeutics Developing the next generation of complement medicines Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for dry age-related macular degeneration/geographic atrophy, a leading cause of blindness. Additional programmes will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company is also developing a unique quantification methodology, the … Type: | 3 | 0 | 2 | 28 |
 | MIP Pharma Group Working to keep you healthy. The MIP Pharma Group (MIP Pharma) produces and sells prescription-only generics, specifically antibiotics, over-the-counter medicines and medical devices. The main markets are Germany and Poland and some other Eastern European markets. MIP Pharma has two production facilities in Saarland/Germany. With around 250 employees, MIP Pharma realised a total turnover of more than €40 million during the last business year. Contact: info@mip-pharma.de Generika, Antibiotika, OTC-Arzneimittel, and Medizinprodukte Type: | 1 | 1 | 0 | 113 |
 | Sino Biological, Inc. Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research. Sino Biological has amassed a global presence with its headquarters in Beijing, China, and subsidiaries in Suzhou and Taizhou, China, the United States, Europe, and Japan. Including two branches in Shanghai and Guangzhou, China, we have over 645,000 square ft of office space and laboratory facilities. Moreover, a new bioprocessing center … Type: | 2 | 1 | 0 | 200 |
 | Menarini Silicon Biosystems Rare cells analysis with single cell precision. Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArrayTM technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision. Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries. Read our Netiquette here: www.siliconbiosystems.com/netiquette cell sorting, … Type: | 1 | 1 | 0 | 176 |
 | The American Academy of Anti-Aging Medicine (A4M) Redefining Medicine A4M is dedicated to the advancement of tools, technology, and transformations in healthcare that can detect, prevent, and treat age-related diseases. A4M further promotes the research of practices and protocols that have the potential to optimize the human aging process. The organization is also dedicated to educating healthcare professionals and practitioners, scientists, and members of the public on biomedical sciences, breaking technologies, and issues related to the anti-aging industry. Our mission is to redefine modern medicine by providing clinicians with the education and resources needed to provide whole person care that optimizes healthspan and vitality for patients worldwide. … Type: | 2 | 1 | 1 | 71 |
 | CELLINK Create the future of health CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company. By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into a thriving $1 billion industry. The company’s best-in-class bioinks, bioprinters, software and services are trusted by the foremost academics in a range of applications, from 3D cell culturing to tissue engineering to drug development, and have been cited in over 700 publications. Furthermore, more than 1,000 laboratories, … Type: | 20 | 8 | 11 | 106 |
 | Cellectis Cellectis is developing life-changing product candidates to target and eradicate cancer cells. Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 24 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains … Type: | 19 | 6 | 8 | 232 |
 | CapEval Pharma CapEval Pharma, founded in 2010, provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Drawing on > 60 years of combined international experience, we are a team of highly qualified pharmaceutical consultants, fluent in 5 languages. We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. With experience working … Type: | 3 | 2 | 0 | 2 |
 | Curileum Discovery Ltd Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology Type: | 0 | 0 | 0 | 3 |
 | TC BioPharm Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine Type: | 0 | 0 | 0 | 50 |
 | Arcede Pharma Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients. Type: | 0 | 0 | 0 | 1 |
 | InSphero Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of ExcellenceTM InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - … Type: | 4 | 0 | 0 | 70 |
 | New Wave Biotech Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing Type: | 9 | 2 | 5 | 9 |
 | Gearbox Biosciences Antibiotic-free recombinant protein production technology in E. coli Antibiotic-free protein production in E. coli protein production and synthetic biology Type: | 1 | 0 | 1 | 6 |
 | ATANIS Biotech AG We revolutionize allergy diagnosis ATANIS Biotech AG has been incorporated as a spin-off company from the University of Bern by the four co-founders Mrs. Noemi Zbären, Prof. Thomas Kaufmann, Prof. Alexander Eggel and Prof. Jean-Pierre Kinet in Summer 2021. The company has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test will additionally be used to assess safety and efficacy of potential new drug candidates for allergy treatment as well as for the evaluation of allergenicity of various food products. The proprietary assay is offered through … Type: | 0 | 0 | 0 | 14 |
 | Nemysis Ltd We are focussed on nutritional and pharmaceutical solutions to cope with Iron Deficiency/Anemia and Gluten Intolerance Based in Dublin, we are a highly focused team of senior individuals, with established networks and track records of research, entrepreneurial and investment success. Nemysis Ltd, a healthcare and pharmaceutical company, is focussed on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances and sensitivities, paying particular attention to the need to safeguard the human microbiome. · Nemysis' novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and Anemia, … Type: | 0 | 0 | 0 | 7 |
 | Delmic Powerful insights, simple workflows Delmic is a passionate high-tech company based in Delft, the Netherlands that develops powerful and user-friendly solutions for electron microscopy, bringing researchers and organizations closer to research insights across diverse application fields. Integration of light and electron microscopy fundamentally impacts imaging by creating the possibility to gain deep insight quickly, easily and reliably. Delmic’s mission is to empower researchers and companies by helping them achieve results that can be trusted implicitly with powerful and user-friendly solutions. Currently, Delmic has two main product lines: cathodoluminescence solutions (SPARC Spectral, SPARC Compact and JOLT) and correlative light and electron … Type: | 2 | 0 | 1 | 61 |
 | Aurealis Therapeutics Multi-target cell and gene therapies for unmet medical needs. Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, … Type: | 1 | 0 | 1 | 17 |
 | Atrandi Biosciences Microfluidics, Single-Cell Analysis, & High-Throughput Screening Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for … Type: | 2 | 1 | 1 | 51 |
 | Sirius Medical Moving from localization to Surgical Marker Navigation Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The company is a spin-off of the Netherlands Cancer Institute, where researchers recognized the need to simplify and improve localization technology for the surgical removal of breast cancers. This led to the development and clinical demonstration of the first magnetic seed localization, a technique that Sirius Medical perfected and further developed into the Sirius Pintuition System. Today, Sirius Pintuition represents the next generation of tumor localization technology, known … Type: | 2 | 0 | 2 | 60 |
 | Sensible Biotechnologies Unlocking the next generation of mRNA medicines. At Sensible Biotechnologies, we are building best-in-class platform for manufacturing of high-quality mRNA in a scalable way to unlock the next generation of mRNA medicines and strengthen the global biosecurity. Type: | 1 | 0 | 1 | 20 |
Startup